1. The Influence of the Minor Short Isoform of Securin (PTTG1) on Transcription is Significantly Different from the Impact of the Full Isoform
   D. E. Demin et al, 2020, Molecular Biology CrossRef
2. The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma
   Yang Wang et al, 2017, Tumor Biology CrossRef
3. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis
   Xinyi Lei et al, 2021, Human Genomics CrossRef
4. Full and D-BOX-Deficient PTTG1 Isoforms: Effects on Cell Proliferation
   D. E. Demin et al, 2022, Molecular Biology CrossRef
5. Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset
   Xiang Liu et al, 2022, Medicine CrossRef
6. Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity
   Xinyu Zhang et al, 2023, Heliyon CrossRef
7. In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma
   Yao-Yu Hsieh et al, 2019, Pathology - Research and Practice CrossRef
8. Prognostic implications of securin expression and sub-cellular localization in human breast cancer
   N. Gurvits et al, 2016, Cellular Oncology CrossRef
9. Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis
   Feng Wang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
10. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
    Yueping Zhan et al, 2015, Computational and Mathematical Methods in Medicine CrossRef
11. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer
    Christoph Fraune et al, 2020, Pathology International CrossRef
12. EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness
    Houda Tabbal et al, 2019, British Journal of Cancer CrossRef
13. SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth
    Tong-bing Wang et al, 2021, Cell Death & Disease CrossRef